On the margins of the 142nd Session of the World Health Organization Executive Board (EB142), we will develop innovative partnerships between governments, investment firms and the private sector to catalyze blended investment in innovations and drive transformational aid for development.

 
At the Transformational Aid for Development Forum, we will initiate a discussion with Heads of UN agencies, members of Family offices and Fund Investors, the WHO, Ministers of Health and representatives from the Private Sector, namely from pharmaceutical, diagnostic and medical device companies. Stakeholders will answer the question: How can we catalyze blended investment to drive innovation and deliver better healthcare to millions of people across the globe?

Co-hosted by UNAIDS, ICV, Johnson & Johnson, BD and the Center for Global Health and Diplomacy (GHD), this special occasion will convene government Ministers who will describe the gaps and challenges they face in their respective countries, members of family offices and investment management firms who will provide insight on their investment approach and the outlook for healthcare investment, and private sector representatives who will share innovations and breakthrough technologies to help people live longer with better quality of life. This unique, invitation-only event will bring together key stakeholders to catalyze blended investment in innovations that can reach the most vulnerable populations.

The Forum will feature the inaugural Innovations Marketplace of the Innovation to Impact Platform (I2I), which will highlight innovations that have been piloted and tested with committed investment capital up to US$100 million. Through targeted demonstrations for investors and government Ministers, the I2I Platform will help to create lasting partnerships between stakeholders, identify investment vehicles to fund promising opportunities, and incorporate policy and national government planning considerations to advance global health.
 
Over the past 20 years, the world has taken unprecedented steps to improve and save lives.

  • Maternal mortality rates have fallen by almost half.
  • In Eastern Asia, Northern Africa and Southern Asia, maternal mortality has declined by around two-thirds.
  • Hundreds of millions of people have emerged from extreme poverty.
  • In 46 countries, women now hold more than 30% of seats in national parliament in at least one chamber.
  • For the world’s wealthiest, real net worth has increased from $1 trillion to almost $7 trillion.
  • And, over the next twenty years, the world’s wealthiest are expected to transfer more than $30 trillion to their children and grandchildren.

 
Despite determined global progress,

  • Every two minutes, a woman dies in childbirth.
  • In sub-Saharan Africa, women are 136 times more likely to die than in developed countries.
  • More than six million children still die before their fifth birthday each year.
  • At the end of 2013, there were an estimated 35 million people living with HIV, and 240,000 children were newly infected.
  • HIV is the leading cause of death for women of reproductive age worldwide.
  • AIDS is now the leading cause of death among adolescents (ages 10–19) in Africa and the second most common cause of death among adolescents globally.

 
This cannot be the world we share.

A measure of a civilization is how it treats its most vulnerable. We can do more. We can create positive change in our lifetimes.

With the involvement of multiple stakeholders, we can work together to catalyze responsible business growth and unlock innovative forms of financing at an unprecedented scale.

In the next 20 years, the brightest minds and breakthrough innovators will leverage their collective resources and shared aspirations to create companies that will reshape traditional industries.

There has never been a greater time in history when capital is being allocated to companies and investors focused on social impact. Therefore, the opportunity to do well by doing good is unprecedented.

Join us on January 22, 2018 as we bridge the gap between political and financial worlds to drive development through 2030 and beyond.

 
 

Good Health and Well-Being. Ensuring healthy lives and promoting the well-being for all at all ages is essential to sustainable development.

Significant strides have been made in increasing life expectancy and reducing some of the common killers associated with child and maternal mortality. Major progress has been made on increasing access to clean water and sanitation, reducing malaria, tuberculosis, polio and the spread of HIV/AIDS. However, many more efforts are needed to fully eradicate a wide range of diseases and address many different persistent and emerging health issues.
 
 
 

Advancing the Global Goals: A New Era of Collaboration

Private sector and public sector stakeholders, and leading leading investors who leverage their talent, influence and capital to identify and grow businesses will share their insights on how to achieve global sustainability.

  • Dr. Tedros Adhanom Ghebreyesus was elected as WHO Director-General for a five-year term by the World Health Organization (WHO) Member States at the Seventieth World Health Assembly in May 2017. He is the first WHO Director-General to have been elected from multiple candidates by the World Health Assembly, and is the first person from the WHO African Region to serve as WHO’s chief technical and administrative officer. Immediately after taking office on 1 July 2017 Dr. Tedros outlined five key priorities for the Organization: universal health coverage; health emergencies; women’s, children’s and adolescents’ health; health impacts of climate and environmental change; and a transformed WHO. Prior to his election as WHO Director-General, Dr. Tedros served as Ethiopia’s Minister of Foreign Affairs from 2012–2016. In this role he led efforts to negotiate the Addis Ababa Action Agenda, in which 193 countries committed to the financing necessary to achieve the Sustainable Development Goals. Dr. Tedros served as Ethiopia’s Minister of Health from 2005–2012, where he led a comprehensive reform of the country’s health system. All roads lead to universal health coverage for Dr. Tedros, and he has demonstrated what it takes to expand access to health care with limited resources. The transformation he led as Ethiopia’s Minister of Health improved access to health care for millions of people. Under his leadership Ethiopia invested in critical health infrastructure, expanded its health workforce, and developed innovative health financing mechanisms. Beyond Ethiopia, Dr. Tedros’ global leadership on malaria, HIV/AIDS, and maternal and child health has been immensely impactful. He was elected as Chair of the Global Fund to Fight AIDS, Tuberculosis, and Malaria Board in 2009, and previously served as Chair of the Roll Back Malaria Partnership Board, and Co-chair of the Partnership for Maternal, Newborn and Child Health Board. Born in the city of Asmara, Eritrea, Dr. Tedros holds a Doctorate of Philosophy (PhD) in Community Health from the University of Nottingham and a Master of Science (MSc) in Immunology of Infectious Diseases from the University of London. Dr. Tedros is globally recognized as a health scholar, researcher, and diplomat with first-hand experience in research, operations, and leadership in emergency responses to epidemics. Throughout his career Dr. Tedros has published numerous articles in prominent scientific journals, and received awards and recognition from across the globe. He received the Decoration of the Order of Serbian Flag in 2016, and was awarded the Jimmy and Rosalynn Carter Humanitarian Award in recognition of his contributions to the field of public health in 2011.

 
 
 

The Future of Health and Well-being of Women, Children and Adolescents

The Global Health Partnership H6 (formerly H4+) has re-confirmed its commitment in relation to the 2016 UN Secretary-General’s Global Strategy for Women’s, Children’s and Adolescents’ Health. The six organizations responsible for promoting and implementing the global health agenda across the United Nations system –UNAIDS, UNFPA, UNICEF, UN Women, WHO and the World Bank Group—have announced that the H6 will focus on the country level and aim to leverage the strengths and capacities of each of the six member organizations in order to support high-burden countries in their efforts to improve the survival, health, and well-being of every woman, newborn, child, and adolescent.
 

 

  • Michel Sidibé is Executive Director of UNAIDS and holds the rank of Under-Secretary-General of the United Nations. Mr Sidibé currently chairs the H6, a partnership that unites and leverages the mandates of six United Nations agencies to deliver on an integrated agenda for the health and well-being of women, children and adolescents. Mr Sidibé’s vision of zero new HIV infections, zero discrimination and zero AID-related deaths has helped drive recent progress in the AIDS response. The goal of having 15 million people living with HIV on antiretroviral therapy by the end of 2015 was achieved nine months ahead of schedule. Access to these life-saving medicines has continued to expand, with 18.2 million people on treatment by mid-2016. Under his leadership of UNAIDS, more and more countries have adopted a Fast-Track approach through which the achievement of a set of measurable targets by 2020 will set the world on course to end the AIDS epidemic as a public health threat by 2030 within the framework of the Sustainable Development Goals. Today, a growing number of countries are also adopting the 90–90–90 targets, whereby 90% of people living with HIV know their status, 90% of people who know their status are accessing treatment and 90% of people on treatment have a suppressed viral load. Mr Sidibé’s leadership in calling for the elimination of new HIV infections among children has contributed to a 60% reduction since 2009 in new paediatric HIV infections in the 21 priority countries of the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. His idea of shared responsibility and global solidarity has been embraced by the international community. This has encouraged an increased ownership of their epidemics by the countries most affected, with domestic resources now accounting for 57% of global AIDS spending. Mr Sidibé’s commitment to advancing global health began in his native Mali, where he worked to improve the health and welfare of the nomadic Tuareg people. He later became Country Director for Terre des Hommes. In 1987, Mr Sidibé joined the United Nations Children’s Fund (UNICEF) in the Democratic Republic of the Congo and went on to serve with UNICEF for 14 years, overseeing programmes across 10 francophone African countries and serving as a country representative in a number of countries. Mr Sidibé’s work has earned him widespread recognition. He has been awarded honorary doctorates from Tuskegee University, Clark University, the University of British Columbia and KwaZulu-Natal University. Since 2007, he has held an honorary professorship at Stellenbosch University. In 2017, he was awarded the Emory President’s Medal in recognition of his work as a “passionate champion for health and humanity.” In 2012, he was named as one of the 50 most influential Africans by the Africa Report and, in 2009, as one of 50 personalities of the year by the French newspaper Le Monde. He is a Knight of the National Order of the Legion of Honour of France, an Officer of the National Order of Mali, an Officer of the National Order of Benin and a Chancellor of the National Order of Chad. He has been awarded an Order of Saint-Charles by Monaco.

 
 
 

Catalyzing For Profit Investment and Innovation for Impact

This strategic session is dedicated to developing innovative partnerships between governments, investment firms and the private sector. We will initiate a discussion with heads of UN agencies, CEOs of investment firms, the WHO, Ministers of Health and representatives from the private sector including pharmaceuticals, diagnostics, IT and investment firms. These stakeholders will answer the question “how do investment vehicles and innovations work together, to deliver better healthcare to millions of people across the globe?”
 

 

  • Gary M. Cohen is Executive Vice President of BD. He is board chair of the CDC Foundation and a board director of the Perrigo Company, UNICEF USA, GBC Health and the Accordia Global Health Foundation. He also serves as a Commissioner for the UN Commission on Life Saving Commodities for Women and Children, chair of the CDC/Corporate Roundtable on Global Health Threats and an advisor to the Clinton Global Initiative. Gary and the BD team are extensively engaged in collaborations across the public, private and NGO sectors to address health needs in developing and emerging countries. He has served as an advocate, speaker and expert panelist on global health, child immunization, HIV/AIDS and health system strengthening, in venues including the United Nations, World Bank, World Economic Forum (Davos), US Department of State and Council on Foreign Relations. Gary founded Together for Girls, a new partnership to address the human rights and public health impacts of sexual violence against girls, comprised of UNICEF, UNAIDS, UNFPA, UN Women, the World Health Organization, the CDC, the US Department of State – Office of the US Global AIDS Coordinator (PEPFAR) and Office of Global Women’s Issues (GWI), the Nduna Foundation, BD and other partners. He has been honored for his humanitarian work by MESAB (Medical Education for South African Blacks), B’nai B’rith International, UNICEF USA, the Nyumbani Home (an orphanage in Kenya for HIV positive children) and the Dikembe Mutombo Foundation. He earned a BA from Rutgers College and a MBA from the Rutgers Graduate School of Management, and previously served on the university’s Board of Trustees.
  • Henrietta H. Fore became UNICEF‘s seventh Executive Director on 1 January 2018. She has worked to champion economic development, education, health, humanitarian assistance and disaster relief in a public service, private sector and non-profit leadership career that spans more than four decades. From 2007 to 2009, Ms. Fore served as the Administrator of the U.S. Agency for International Development (USAID) and Director of United States Foreign Assistance. The first woman to serve in these roles, she was responsible for managing $39.5 billion of U.S. foreign assistance annually, including support to peoples and countries recovering from disaster and building their futures economically, politically and socially. Earlier in her career at USAID, Ms. Fore was appointed Assistant Administrator for Asia and Assistant Administrator for Private Enterprise (1989-1993). She served on the Boards of the Overseas Private Investment Corporation and the Millennium Challenge Corporation. In 2009, she received the Distinguished Service Award, the highest award the Secretary of State can bestow. From 2005 to 2007, Ms. Fore served as Under Secretary of State for Management, the Chief Operating Officer for the U.S. Department of State. She was responsible for the staff, resources, facilities, technology and security of the Department and was the Secretary of State’s principal advisor on management issues. She oversaw a management budget of $3.6 billion, 7,200 employees, 30,000 contractors and 267 embassies and posts in 172 countries. From 2001 to 2005, Ms. Fore was the 37th Director of the United States Mint in the U.S. Department of Treasury, managing the world’s largest manufacturer of coins, medals and coin products. In 2005, she received the Alexander Hamilton Award, the Department of Treasury’s highest honor. Immediately prior to her appointment with UNICEF, Ms. Fore was Chairman of the Board and Chief Executive Officer of Holsman International, a manufacturing and investment company. She also served on the boards of a number of domestic and international public corporations, including as Global Co-Chair of the Asia Society, Chair of the Middle East Investment Initiative, and Co-Chair of WomenCorporateDirectors. She also served on the boards of the Center for Strategic and International Studies (CSIS), the Aspen Institute, the Committee Encouraging Corporate Philanthropy (CECP) and the Center for Global Development (CGD). Ms. Fore has a Bachelor of Arts in History from Wellesley College and a Master of Science in Public Administration from the University of Northern Colorado. She is married and has four children.
  • Ndaba Mandela is Chairman of Africa Rising Foundation. Nelson Mandela had a “long walk to freedom”, yet his footprints still remain. Following in the footsteps of his beloved and iconic grandfather, Ndaba Mandela has taken the torch – and ran with it. Today, Nelson Mandela’s legacy continues as Ndaba keeps its beacon of hope bright, fueling its fiery message that one person can make a difference. Thankfully for all, the legacy lives, as Ndaba was recently named one of the “28 Men of Change” by BET. Today, Ndaba is showing the world, through his actions and orations, that Nelson Mandela’s voice and message of freedom still carries and rings true – sounded by a child that became a man under the warm embrace and expert tutelage of one of history’s greatest teachers. He continues to keep Mandela on the world’s mind.

 

“I carry with me the values of my grandfather. I am an African, and I know what it means to be African, and I’m proud of it.”

 – Ndaba Mandela

 

  • Khawar Mann, is a Partner at The Abraaj Group responsible for the healthcare team. Mr. Mann was previously co-head of the healthcare team at Apax Partners and led investments across Europe and Asia. He was also Chairman and President of Medsi Group, Russia’s largest private healthcare sector institution. Mr. Mann is the co-founder of Mosaic, a UK-based charity that mentors young adults in deprived communities, for which he received the Order of the British Empire (OBE). He is also Chairman of the UK Thouron Selection Committee, a prestigious award for graduate students aimed at promoting closer ties between the United Kingdom and the United States. Mr. Mann holds an MBA from the Wharton School and an MA in Medical Sciences and Law from Cambridge University. He was a Fulbright scholar and a Thouron alumni.
  • Chuck Slaughter is the Founder and CEO of Living Goods. Chuck founded TravelSmith and grew it to over two million customers and $100 million in sales. After selling TravelSmith in 2004, Chuck devoted his entrepreneurial instincts to building vibrant enterprises in both the private and social sectors. In affiliation with the private equity firm Golden Gate Capital he participated in the acquisition and turnaround of 10 major apparel brands with combined sales over $2 billion including Spiegel, Newport News, Norm Thompson, and Express. As pro-bono president, Chuck led the turnaround of the HealthStore/CFW Shops, a system of micro-franchised clinics serving the poor in Kenya. Chuck currently serves on the boards of The Initiative for Global Development, the Horace W. Goldsmith Foundation, Three Day Blinds, and Living Goods, and is a former board member of Spiegel Brands. He is a recipient of the Ernst and Young Entrepreneur of the Year Award and is a Draper Richards Fellow. Chuck earned both a BA and a MA in Public and Private Management from Yale. He resides in California with his wife Molly and sons Cooper, Riley, and Jackson.
  • Robert Smith is the founder of ICV. He serves as Business Strategy Advisor to New Frontier Bio, a multi-asset holding company, which leverages the long-term involvement of the Kennedy family in healthcare, to identify, finance and develop novel medical technologies from inception through clinical proof of concept; he serves as a a member of the Presidential Advisory Board of Jefferson, the largest academic medical center in Philadelphia and ranked #16 by U.S. News and World Report; Robert serves Senior Advisor for Fundraising and Partnerships to the Permanent Secretariat of the World Summit of Nobel Peace Laureates, a platform to consolidate peace efforts and strengthen global security, monitor and support the Nobel Peace Laureates, and engage the minds of young people and citizens on real matters that broaden vision and open up new horizons for more peaceful and compassionate thinking; and he serves as a member of the Advisory Council of  Represent.Us, which brings the left and the right together to create positive change for American democracy. Robert serves as a member of the Board of Directors of The Chaeli Foundation (USA), Childhood Cancer Kids, The Children’s Village, Tuesday’s Children, The Harmon Foundation.
  • Dr. William Steiger serves as Chief of Staff at the U.S. Agency for International Development. From 2013 to 2017, Dr. Steiger was successively Managing Director and Chief Program Officer at Pink Ribbon Red Ribbon, the leading international initiative against breast and cervical cancer in sub-Saharan Africa and Latin America. During 2012, Dr. Steiger was a Senior Advisor to the General Manager of the Global Fund to Fight AIDS, Tuberculosis and Malaria. Among other tasks, he helped restructure the Fund’s Secretariat and design the organization’s new funding and grant-making model. In 2011, Dr. Steiger served as the staff director for the High-Level, Independent Panel that reviewed the Global Fund’s fiduciary controls, grant-making, risk-management and administration. The Panel’s report was the impetus for a wide-ranging reforms at the institution. Dr. Steiger also worked as a Senior Advisor for International Affairs at consulting firm Leavitt Partners, working on food-safety and global health projects. From 2001 to 2009, he was Special Assistant to the Secretary for International Affairs and the Director of the Office of Global Health Affairs at the U.S. Department of Health and Human Services (HHS). During his eight years as Director of the HHS Office of Global Health Affairs, Dr. Steiger advised the Secretary and Deputy Secretary on global health, international family and social-affairs issues; coordinated overseas programs and spending; developed relationships with foreign governments and U.S. embassies and missions; and managed international travel and staffing. Dr. Steiger represented HHS at various multilateral organizations on behalf of the U.S. Government. Dr. Steiger has served as the U.S. Member of the Executive Board of the World Health Organization, President of the Executive Committee of the Pan-American Health Organization, and U.S. Member and Alternate Member on the Board of Directors of the Global Fund to Fight AIDS, Tuberculosis, and Malaria. He acted as the HHS Secretary’s liaison to the National Security Council, the U.S. Department of State, and the U.S. Agency for International Development. He also served as the Department’s representative to the Office of the U.S. Global AIDS Coordinator in the implementation of the President’s Emergency Plan for AIDS Relief (PEPFAR), and to the Steering Committee that manages the President’s International Malaria Initiative. Dr. Steiger earned a Ph.D. in Latin American History at the University of California, Los Angeles, and a bachelor’s degree in History, summa cum laude, from Yale.

 
 
Plenary I: Strategies to Forge Innovative Partnerships in Global Health

The environment has never been more conducive to forging new partnerships between public and private sector actors. The Sustainable Development Goals calls for individuals, governments, institutions, and firms to work together, and the private sector’s interests to contribute to development efforts grows each day. Partnership development, however, remains a difficult enterprise due to different and sometimes competing objectives and intentions. For instance, how can outcomes- and results-based approaches co-exist with growth- and profit-oriented objectives? How can accountability to the taxpayers be achieved within the framework of accountability to shareholders and investors? Is it even possible to quantify and monetize efforts that aim to “save lives”?

This plenary will focus on the challenges in creating public-private sector partnerships within the global health sphere. Participants will share their experiences and lessons while also discussing the critical conditions and elements needed to achieve success in areas such as blended financing, service delivery, and research and development.
 
 
Plenary II: Examining the Challenges and Opportunities Related to the Financing, Development, and Scale-up of Innovations

“There is never a shortage of ideas” is a refrain often heard when it comes to innovations and global health. From major pharmaceutical companies to individual researchers and inventors, new approaches, techniques, tools, and equipment are being created every day. For developers, questions often asked are, “How do I get my ideas heard, funded, and tested?” “How can I work with others who may have similar ideas or can assist with implementation and rolling out?” “After my invention has been proven to be effective, how can it be scaled up?”

On the other side of the equation, countries are expressed concerns that there are too many ideas being delivered too quickly. For many low- to middle-income countries, it takes several years to full integrate a new technology, a piece of equipment, or new approach because health professionals and workers need to be informed and educated about the new tool, systems need to be adjusted, and this new resource must be evaluated. With the flood of ideas, countries cannot keep up, yet at the same time they need advice on what item is the most effective and efficient to respond to their unique needs.

This plenary will examine the challenges and opportunities related to the financing, development, and scale-up of innovations. The perspectives of financers, innovators, and countries will be shared to provide a balance perspective – i.e., the supply and demand side of the equation.
 
 

Innovation Showcase

At ICV Geneva 2018: Transformation Aid for Development, we will feature innovations from many different sectors, some directly related to healthcare some tangentially related to healthcare and supported by UNITAID, Finland and other G7 governments. Most of the innovations have been piloted and have commitments in the range of US$ 40-60 million.These innovations will showcase products from new methods of detecting HIV to a brand new proprietary building technique to bring affordable, quality housing to millions of people to new data platforms for healthcare in the emerging markets. This marketplace will bring together the public sector, the private sector, investors and innovators all of the components necessary to develop lasting partnerships going forward. Innovators will showcase their products during scheduled breaks and the lunch hour.
 
 

 
 

 
 

 
 
Venue

United Nations Office at Geneva
Palais des Nations
1211 Genève, Switzerland

Directions
 


United Nations Office at Geneva
Palais des Nations
1211 Genève, Switzerland

Directions
 

InterContinental Geneve
Chemin du Petit-Saconnex 7-9, 1209
Genève, Switzerland

Directions


 

Agenda
 
07:30 AM      
START END
United Nations Office at Geneva
   
07:30 09:30 Plenary Session I: Strategies to Forge Innovative Partnerships in Global Health  
09:30 09:45 Break
09:45 11:00 Plenary Session II: Examining the Challenges and Opportunities related to the Financing, Development and Scale-up of Innovations  
11:00 11:15 Break
07:30 8:30 Catalyzing Blended Investment in Innovation  
08:30 11:30 The Future of Health and Well-Being of Women, Children and Adolescents  
12:00 13:00 Lunch
10:20 10:40 InterContinental Geneve  
14:00 16:00 Innovation to Impact (I2I) Marketplace  
16:00 16:10 Closing Remarks